Synlogic to Present at Upcoming Investor Conferences in November
November 08 2017 - 4:05PM
Business Wire
Synlogic (Nasdaq: SYBX) announced today that JC Gutiérrez-Ramos,
Ph.D., Synlogic’s president and chief executive officer, will
present at the following conferences in November:
- The Stifel 2017 Healthcare Conference
at 11:45 am ET on November 15th, 2017, in New York City
- The Jefferies 2017 London Healthcare
Conference at 5:20 pm GMT (12:20 pm ET) on November 16th, 2017, in
London, UK
- The 29th Annual Piper Jaffray
Healthcare Conference at 11:00 am on November 29th, 2017, in New
York City
Live webcasts of each of the presentations can be accessed under
“Event Calendar” in the Investors & Media section of the
Company’s website. Archived webcast recordings will be available on
the Synlogic website for approximately 30 days after each
event.
About Synlogic:Synlogic is pioneering the development of
a novel class of living treatments, Synthetic BioticTM medicines,
based on its proprietary drug development platform. Synlogic’s
initial pipeline includes Synthetic Biotic medicines for the
treatment of rare genetic diseases, such as Urea Cycle Disorder
(UCD) and Phenylketonuria (PKU). In addition, the company is
leveraging the broad potential of its platform to create Synthetic
Biotic medicines for the treatment of more common diseases,
including liver disease, inflammatory and immune disorders, and
cancer. Synlogic is collaborating with AbbVie to develop Synthetic
Biotic-based treatments for inflammatory bowel disease (IBD). For
more information, please visit www.synlogictx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108005963/en/
MEDIA CONTACT:For SynlogicCourtney Heath,
617-872-2462courtney@scientpr.comorINVESTOR
CONTACT:SynlogicElizabeth Wolffe, Ph.D.,
617-207-5509liz@synlogictx.com
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Apr 2023 to Apr 2024